Blood pressure variability under basal conditions and blood pressure reactivity to emotional stress were studied in 38 hypertensives and 13 normotensives. Systolic basal blood pressure variability correlated with systolic blood pressure reactivity. Variability increased with higher basal blood pressure. Thus in the hypertension group the blood pressure variability was greater than in the normotension group. Besides, the hypertension group showed a greater reactivity of systolic blood pressure to emotional stress, too. An influence of age on basal blood pressure, blood pressure variability, and reactivity could be evaluated; but no influence of sex on these parameters was detected. The results indicate that variability and reactivity of blood pressure can be referred to a common central nervous blood-pressure-regulating mechanism. As both parameters are increased in hypertension, a greater lability of blood pressure must be assumed. This greater lability may be attributed to a stronger neurogenic influence or to structural changes of peripheral blood vessels.
In 100 children (63 boys and 37 girls) aged 11.3 +/- 0.6 years ambulatory blood pressure (BP) was recorded by a semi-automatic device (Remler) 9 times per year over a period of 3 years. A sex difference in systolic BP was noted from the age of 13 years on with boys having higher values by about 6 mmHg (p less than .05). This could not be explained by differences in weight. In boys parental hypertension was associated with higher systolic values independent on age (p less than .05). Genetic and hormonal factors seem to influence BP during male puberty independently from each other.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.